Drugs Flashcards
Induces free radical formation to break DNA strands
Anti-tumor antibiotic
Bleomycin
Intercalates into DNA preventing RNA synthesis
Anti-tumor antibiotic
Dactinomycin
Generates free radicals and intercalates into DNA to break DNA as well as interfere with Topoisomerase II
Anti-tumor antibiotic
Anthracyclines
–rubicins
Prevents IL-2 transcription; Binds Cyclophilin. Inhibits Calcineurin. Immunosuppresant
Cyclosporin
Prevents IL-2 transcription; binds FK506/ FKBP; inhibits Calcineurin. Immunosuppresant
Tacrolismus
mTOR inhibitor; binds FKBP; Prevents IL-2 response. Immunosuppresant
Sirolismus
Blocks the IL-2 Receptor directly
Immunosuppresant
Basiliximab
Daclizumab
Blocks Nucleotide synthesis (purines) thus inhibiting lymphocyte proliferation. Immunosuppresant
Azothiprine
6MP
Reversibly inhibits IMP DHAse preventing purine synthesis of B & T cells. Immunosuppresant
Mycophenolate Mofetil
Inhibits NFKB to reduce the transcription of cytokines. Induces T cell and Eosinophil apoptosis. Immunosuppresant.
Glucocorticoids
Antibody that targets:
Platelet GPIIb/IIIa
ABCiximab
Antibody that targets:
Rank-L
Denosumab
helps preserve bone dnesity
Antibody that targets:
IgE
Omalizumab
Antibody that targets:
RSV F protein
Palivizumab
Autoimmune therapeutic antibody that targets:
TNF- alpha
RA, IBD, Psoriasis
Infliximab
adalimumab
Autoimmune therapeutic antibody that targets:
C5 complement
Paroxysomal Nocturnal Hemeglobinuria
Eculizumab
Autoimmune therapeutic antibody that targets:
IL-17A
Psoriasis
IxeKizumab
secukinumab
Autoimmune therapeutic antibody that targets:
Alpha-4 Integrin
MS, IBD (PML risk)
Natalizumab
Autoimmune therapeutic antibody that targets:
IL-12/IL-23
Psoriasis
Ustekinumab
Cancer therapy antibody that targets:
CD52
CLL, MS
Alemtuzumab
Cancer therapy antibody that targets:
VEGF
RCC, Colon Cancer, Lung cancer
Bevisizumab
Cancer therapy antibody that targets:
CD20
CLL, MS, RA, Non-Hodgkin B cell lymphomas
Rituximab
Cancer therapy antibody that targets:
HER2
Breast/GI cancer
Trastuzumab
General Type I DM treatment
Insulin
General Type II DM treatment
Metformin (1st line) Weight loss, Non-Insulin injectables, Insulin
Gestational DM
Nutrition/ Exercise (1st line)
Insulin Replacement
For DKA & stress hyperglycemia use
Rapid acting insulin
mnemonic for DM drugs
To Normalize Pancreatic Function
Glit, Glin, Glip, Glif
Rapid Acting Insulin that peaks in and Hour
3
Lispro
Aspart
Glulisine
(no LAG)
Regular Short acting insulin peaks at ___ hours
2–3
Intermediate acting insulin that peaks at 4–10 hours
NPH
Long acting insulin with no real peak
Determine, Glargine
Adverse Effects include
Weight Gain
Hypoglycemia
Lipodystrophy
Insulin
inhibits mGPD to ↓ Gluconeogenesis & Glucagon.
↑ Glycolysis & Insulin
Metformin (Biguanides)
Activates PPAR- GAMMA to ↑ insulin sensitivity/ adiponectin
–Glitazones
Glitazones–Gamma
Close K+ channels in pancreatic Beta cells to depolarize and ↑ insulin secretion via Calcium influx
Sulfonyureas
(1:Chlopropamide, Tolbutamide)
(2: Glipizide, GLyburide)
Meglitinides (–glinides)
↓ Glucagon & Gastric emptying
↑ Glucose DEPENDENT insulin release
GIP-1 analogs
Exenatide
Liraglutide
Inhibit DPP4 enzymes
↓ GIP-1 causing ↓ Glucagon & gastric emptying
↑ Glucose DEPENDENT insulin release
–Gliptins
Block Glucose reabsorption in the PCT
SGLT2 inhibitors
–Gliflozin
Inhibit intestinal brush border alpha-glucosidase to ↓ glucose absorption & post-meal hyperglycemia
Acarbose
Miglitol
↓ Glucagon release & Gastric Emptying
Amylin Analog
Pramlintide
Use with/ Caution in Renal Insufficiency Diabetes Drugs (4)
Metformin
SGLT-2 inhibitors
Sulfonylureas
–Glinides
Diabetes drugs contraindicated in Renal Insufficiency
Acarbose
Miglitol
Diabetes Drugs
causes B12 deficiency
Lactic Acidosis
Metformin
Diabetes Drugs
causing weight gain
–Glitazones
–Glinides
Sulfonylureas
Diabetes Drugs
causing weight loss
Metformin
Exenatide, Liraglutide
–Gliflozins
Diabetes Drugs
Efficacy ↓ with ↓ GFR
–Gliflozins
Diabetes Drugs
causes Edema, HF, fractures
–Glitazones
Diabetes Drug
causes Disulfram like reaction
Chlorpromide
Tolbutamide
Diabetes Drugs
causes ↑ risk of MI & Cardiovascular death
Rosiglitazone
Diabetes drug causes hypoglycemia
–Glinides
Sulfonylureas
Pramlintide
Diabetes drugs that cause
UTIs
Vulvovaginal Candidiasis
Orthostatic Hypotension (fall risk)
–Gliflozins
↓ Aqueous humor synthesis. Beta blockers (3)
Timolol
Betaxolol
Carteolol
↓ Aqueous humor synthesis via vasoconstriction. Alpha agonist
Epinephrine
↓ Aqueous humor synthesis. Alpha agonist
Apraclonidine
Brimonidine
↓ Aqueous humor synthesis via inhibition of carbonic anhydrase
Acetazolamide
↑ Aqueous humor outflow via contraction of ciliary muscles. N3 Cholinomimetics.
Direct: Pilocarpine
Indirect: Physostigmine, Echothiophate
↑ Aqueous humor outflow via ↓ resistance to flow through the uveoscleral canal via prostaglandins
Latanoprost
Bimatoprost
Darkens the color of the Iris & ↑ eyelash growth
Latanoprost
Bimatoprost
↑ PPAR- ALPHA ↑ Lipoprotein lipase ↑ TG clearance
↑ risk of Gallstones
↑ Cholesterol ↓ Bile acid production
–FIbrates
Gemfirozil
The insulin receptor is a ____ receptor which induces autophosphorylation
Transmembrane Tyrosine Kinase
Insulin __ glucose reabsorption and glycolysis
↑
Stimulates pancreatic Beta cells to release secretory granules
Glimiperide
Sulfonylurea
Inhibits alpha glucosidase (breaks down of carbohydrate dissacharides) resulting in ↓ glucose absorption
Acarbose (good post meal control)
1st line oral hypoglycemic agent inhibit mitochondrial Glycerolphosphate DHase & ↓ gluconeogenesis
Metfromin
Metfromin is contraindicated in renal failure and
Heart Failure
↑ adipokines (adiponectin, leptin, omentin) transcription
Pioglitazone
Hydrolyzes dipeptides bonds on polypeptides
Diabetes drugs
–Gliptins
Glucose clearance approximately =’s GFR when there is ____ glucose reabsorption
zero
SGLT2 inhibitors
Ach Esterase inhibitor ↑ Ach.
1st line treatment for Alzheimer disease.
May cause Insomnia
Donepezil
Rivastigmine
Galantine
NMDA (glutamate) receptor antagonist; helps prevent excitotoxicity (mediated by calcium)
Memantine
*AE: Hallucination
↓ Neuronal Gultamate excitotoxicity.
↑ SURVIVAL
Riluzole
ALS- Lou Gerig’s
Inhibits vesicular monoamine transporter (VMAT) causing ↓ Dopamine vesicle packaging and release
Tertrabenazine
Huntington Chorea/ Dyskinesia
Parkinson drug
Dopamine Agonist
Bromocriptine, Ropinirole, Pramipexole
↑ Dopamine release
↓ Dopamine re-uptake
Enhances effects of Dopamine
Amantadine
Dopamine agonist that can also be used for Hyperprolactinemia
Bromocriptine
Dopamine agonist that has a long half life & delays the need to start Levodopa (thus postponing motor symptoms)
Bromocriptine
Blocks peripheral conversion of L-Dopa to Dopamine by inhibiting DOPA carboxylase.
(Reduces N/V symptoms)
Carbidopa
+ L-Dopa
Agents prevent peripheral (Pre-BBB) L-Dopa degradation to ↑ central L-Dopa
Levodopa
Carbidopa
Entacapone
Talcapone
Prevent peripheral L-Dopa degradation to 3-OMD by inhibiting COMT. Used in conjunction with Levodopa
Entacapone
Talcapone
Agents act centrally (Post-BBB) to inhibit breakdown of Dopamine
Selegine
Rasagiline
Talcapone
Block conversion of Dopamine into DOPAC by selectively inhibiting MAO-B
Selegine
Rasagiline
Crosses BBB and blocks conversion of Dopamine to 3-MT in the brain by inhibiting central COMT
Talcapone
Anticholinergics/muscarinic that improves the tremor and rigidity of drug induced Parkinson
Benzotropine
Trihexyphenidyl
Can lead to On/Off phenomenon with improved mobility during on periods and reduced motor function during off period.
Carbidopa/Levodopa